These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33687652)

  • 41. Management of Lead Encephalopathy with DMSA After Exposure to Lead-Contaminated Moonshine.
    Arnold J; Morgan B
    J Med Toxicol; 2015 Dec; 11(4):464-7. PubMed ID: 26245877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug shortages lead to action.
    Lee J
    Mod Healthc; 2011 Jul; 41(29):16. PubMed ID: 21853599
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug shortages: the cycle of quantity and quality.
    Kweder SL; Dill S
    Clin Pharmacol Ther; 2013 Mar; 93(3):245-51. PubMed ID: 23340474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis.
    Pepin J; Milord F
    Trans R Soc Trop Med Hyg; 1991; 85(2):222-4. PubMed ID: 1887477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recognition and management of children with increased lead absorption.
    Chisolm JJ; Barltrop D
    Arch Dis Child; 1979 Apr; 54(4):249-62. PubMed ID: 110270
    [No Abstract]   [Full Text] [Related]  

  • 46. 2,3-Dithioerythritol, a possible new arsenic antidote.
    Boyd VL; Harbell JW; O'Connor RJ; McGown EL
    Chem Res Toxicol; 1989; 2(5):301-6. PubMed ID: 2562424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. OX-217 (B.A.L.) as an antidote in complication of arsenic therapy.
    SRIVASTAVA SC
    Clin Soc J; 1947 Nov; 11(2-3):48. PubMed ID: 18916140
    [No Abstract]   [Full Text] [Related]  

  • 48. British anti-lewisite (BAL), the classic heavy metal antidote.
    Oehme FW
    Clin Toxicol; 1972; 5(2):215-22. PubMed ID: 4559017
    [No Abstract]   [Full Text] [Related]  

  • 49. Antidote availability in Quebec hospital pharmacies: impact of N-acetylcysteine and naloxone consumption.
    Bailey B; Bussières JF
    Can J Clin Pharmacol; 2000; 7(4):198-204. PubMed ID: 11118966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Neurological symptomatology in cases of chronic mercury poisoning in children].
    Gościńska Z; Bartoszewicz B; Piasecka M
    Pediatr Pol; 1967 Mar; 42(3):297-303. PubMed ID: 6042929
    [No Abstract]   [Full Text] [Related]  

  • 51. BAL therapy in lead poisoning.
    GIANNATTASIO RC
    N Y State J Med; 1956 Nov; 56(22):3510-1. PubMed ID: 13369801
    [No Abstract]   [Full Text] [Related]  

  • 52. Inadequate stocking of antidotes in Taiwan: is it a serious problem?
    Ong HC; Yang CC; Deng JF
    J Toxicol Clin Toxicol; 2000; 38(1):21-8. PubMed ID: 10696920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antidote availability in Norway].
    Solheim L; Andrew E; Jacobsen D
    Tidsskr Nor Laegeforen; 2002 Apr; 122(11):1111-3. PubMed ID: 12043055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural requirements for chelate antidotal efficacy in acute antimony(III) intoxication.
    Basinger MA; Jones MM
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):355-63. PubMed ID: 6264554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Recent therapeutic conquests in extrapyramidal syndromes].
    Schergna E
    Minerva Med; 1970 Dec; 61(101):5829-35. PubMed ID: 4322470
    [No Abstract]   [Full Text] [Related]  

  • 56. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care.
    Dart RC; Borron SW; Caravati EM; Cobaugh DJ; Curry SC; Falk JL; Goldfrank L; Gorman SE; Groft S; Heard K; Miller K; Olson KR; O'Malley G; Seger D; Seifert SA; Sivilotti ML; Schaeffer T; Tomassoni AJ; Wise R; Bogdan GM; Alhelail M; Buchanan J; Hoppe J; Lavonas E; Mlynarchek S; Phua DH; Rhyee S; Varney S; Zosel A;
    Ann Emerg Med; 2009 Sep; 54(3):386-394.e1. PubMed ID: 19406507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Subacute saturnism caused by accidental self-inflicted wound treated with dimercaprol (BAL); etiopathogenic and medicolegal aspects].
    MARCONI E
    Arch Med Interna; 1953; 5(5):159-74. PubMed ID: 13181625
    [No Abstract]   [Full Text] [Related]  

  • 58. A regional database of antidote availability.
    Mirza M; Saini D; Dickens MA; Kazzi Z; Orthner HF
    AMIA Annu Symp Proc; 2006; 2006():1034. PubMed ID: 17238653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of BAL and BAL glucoside in acute lead acetate poisoning.
    WEATHERALL M
    Br J Pharmacol Chemother; 1948 Jun; 3(2):137-45. PubMed ID: 18866992
    [No Abstract]   [Full Text] [Related]  

  • 60. [Action of dimercaprol (BAL) on the experimental poisoning of the cynocephale monkey (Papio papio) with dibutyl lead diacetate (DPD). Comparison with toxicity to rats].
    Gras G; Giono H
    C R Seances Soc Biol Fil; 1971; 165(7):1796-800. PubMed ID: 4261950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.